Nephros, Inc.
NEPH
$2.90
$0.124.32%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -0.73% | 7.81% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.73% | 7.81% | |||
| Cost of Revenue | 6.44% | 13.85% | |||
| Gross Profit | -5.28% | 4.29% | |||
| SG&A Expenses | 3.90% | 1.27% | |||
| Depreciation & Amortization | -5.88% | -2.86% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.87% | 6.69% | |||
| Operating Income | -94.27% | 26.61% | |||
| Income Before Tax | -81.76% | 38.21% | |||
| Income Tax Expenses | -100.00% | -66.67% | |||
| Earnings from Continuing Operations | -81.60% | 42.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -81.60% | 42.19% | |||
| EBIT | -94.27% | 26.61% | |||
| EBITDA | -85.63% | 23.84% | |||
| EPS Basic | -81.76% | 41.96% | |||
| Normalized Basic EPS | -82.00% | 37.93% | |||
| EPS Diluted | -80.67% | 50.00% | |||
| Normalized Diluted EPS | -81.77% | 35.21% | |||
| Average Basic Shares Outstanding | 0.33% | 0.11% | |||
| Average Diluted Shares Outstanding | 1.49% | 2.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||